China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

Biopharmaceutical company Boehringer Ingelheim is using data and more to drive organizational change and has outlined four ...

Biopharma financings totaled $21.38 billion through May 2025, down sharply from $62.57 billion during the same period in 2024 ...

After a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of ...

At the ASMS Conference in Baltimore, the company highlighted several new products tailored to a range of application areas, ...

Sionna Therapeutics shares rose after reporting positive preliminary data from its cystic fibrosis drug trial. Shares traded 5.9% higher at $16.92.

Immix Biopharma, Inc. (IMMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

Shares of Liminatus Pharma rose in post-market trading after the pre-clinical stage biopharmaceutical company said it regained compliance with Nasdaq listing requirements. The stock rallied 77% to $22 ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and ...